Pharmaceutical group · United Kingdom
Hikma
A group of 15 companies with 625 medicines in 7 countries.
Group structure
15 companies in 7 countries
Loading…
Pharmaceutical group · United Kingdom
A group of 15 companies with 625 medicines in 7 countries.
15 companies in 7 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 625
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| 0.9% SODIUM CHLORIDE INJECTION USP9 mg / ml · Solution | Sodium chloride | Canada | Marketed | 2008 |
| ABIRATERONE ACETATE125mg | 250mg | 500mg · Tablet | Abiraterone | United States | Marketed | 2018 |
| ACETYLCYSTEINE SOLUTION USP200 mg / ml · Solution | Acetylcysteine | Canada | Marketed | 2018 |
| Aciclovir Hikma 250 mg poeder voor oplossing voor infusiePoeder voor oplossing voor infusie | Aciclovir | Netherlands | Authorised | 2022 |
| ACICLOVIR HIKMA 250 MG POLVO PARA SOLUCION PARA PERFUSION EFG250 mg · Polvo para solución para perfusión | Aciclovir | Spain | Marketed | 2018 |
| Aciclovir Hikma 500 mg poeder voor oplossing voor infusiePoeder voor oplossing voor infusie | Aciclovir | Netherlands | Authorised | 2022 |
| ADENOSINA HIKMA 6 MG/2ML SOLUCION INYECTABLE EFG3 mg/ml · Solución inyectable | Adenosine | Spain | Marketed | 2021 |
| ADENOSINE3mg/ml · Injectable | Adenosine | United States | Marketed | 2004 |
| Adenosine Hikma 6 mg/2 ml, oplossing voor injectieOplossing voor injectie | Adenosine | Netherlands | Authorised | 2021 |
| ALENDRONATE SODIUM70mg base/75ml · Solution | Alendronic acid | United States | Marketed | 2013 |
| ALPRAZOLAM1mg/ml · Concentrate | Alprazolam | United States | Marketed | 1993 |
| ALPROSTADIL0.5mg/ml · Injectable | Alprostadil | United States | Marketed | 1998 |
| AMFOTERICINA B LIPOSOMAL HIKMA 50 MG POLVO PARA CONCENTRADO PARA DISPERSION PARA PERFUSION50 mg · Polvo para dispersión para perfusión | Amphotericin b | Spain | Authorised | 2026 |
| AMICAR1gm | 500mg · Tablet | Aminocaproic acid | United States | Marketed | 1964 |
| AMICAR0.25gm/ml · Solution | Aminocaproic acid | United States | Marketed | 1964 |
| AMINOCAPROIC500mg · Tablet | Aminocaproic acid | United States | Not marketed | 2001 |
| Amiodaron HCl Hikma, 50 mg/ml oplossing voor injectieOplossing voor injectie | Amiodarone | Netherlands | Authorised | 2007 |
| AMOXICILLIN125mg/5ml | 200mg/5ml | 250mg/5ml | 400mg/5ml · For suspension | Amoxicillin | United States | Marketed | 1978 |
| AMOXICILLIN AND CLAVULANATE POTASSIUM125mg/5ml; 31.25mg base/5ml | 200mg/5ml; 28.5mg base/5ml | 250mg/5ml; 62.5mg base/5ml | 400mg/5ml; 57mg base/5ml | 600mg/5ml; 42.9mg base/5ml · For suspension | Amoxicillin, Clavulanic acid | United States | Marketed | 2002 |
| ANIDULAFUNGINA HIKMAPolvere per concentrato per soluzione per infusione | Anidulafungin | Italy | Authorised | |
| ANIDULAFUNGINA HIKMA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG100 mg · Polvo para concentrado para solución para perfusión | Anidulafungin | Spain | Authorised | 2026 |
| Anidulafungine Hikma 100 mg poeder voor concentraat voor oplossing voor infusiePoeder voor concentraat voor oplossing voor infusie | Anidulafungin | Netherlands | Authorised | 2026 |
| ATIVAN2mg/ml | 4mg/ml · Injectable | Lorazepam | United States | Marketed | 1980 |
| ATROPINE INJECTION BP0.4 mg / ml · Solution | Atropine | Canada | Marketed | 2015 |
| ATROPINE INJECTION BP0.6 mg / ml · Solution | Atropine | Canada | Marketed | 2016 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Saudi Arabia | 193 | 193 | 0 | CompaniesAll medicines |
| United States | 162 | 158 | 4 | CompaniesAll medicines |
| Canada | 105 | 95 | 10 | CompaniesAll medicines |
| Netherlands | 89 | 89 | 0 | CompaniesAll medicines |
| Spain | 74 | 73 | 1 | CompaniesAll medicines |
| European Union (EMA) | 1 | 1 | 0 | CompaniesAll medicines |
| Italy | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Brazil, Colombia, Croatia, France, Germany, Malaysia, Serbia, Singapore, Sweden, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), published shortage reports CSV, retrieved 2026-10-28.
Licence: commercial redistribution permission not established
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
BDPM / ANSM, HAS and UNCAM, CIS_MITM.txt, published 13/10/2026, acquired 2026-10-25T22:15:46.803459+00:00; exact facts retained, no endorsement.
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026; publication updated 7 October 2026; source PDF periods January–September 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.
Licence: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA grant registers
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
AIFA, https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv, HTTP Last-Modified Mon, 26 Oct 2026 00:02:13 GMT, acquired 2026-10-26T09:43:33.749886+00:00; factual native values retained; exact row correspondence and projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licence: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licence: Italian Open Data Licence
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Läkemedelsverket, Sweden, Förvaringstemperatur och hållbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.
Keep Hikma’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.
Ranked by their number of medicines.